New Indian Price Caps Loom Amid Gains For Patients
This article was originally published in Scrip
Executive Summary
India's national list of essential medicines (NLEM) 2015 is estimated to cover an additional INR77.84bn ($1.17bn) worth of drugs across therapy segments, extending the scope of price controls to certain new products while bringing significant savings to patients.